Linda A. Chatman

Discovery of Two Clinical Histamine H ₃ Receptor Antagonists: <i>trans</i> - <i>N</i> -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i> -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- <i>N</i> -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)

Travis T. Wager, Betty Pettersen, Anne W. Schmidt et al. · Journal of Medicinal Chemistry · 2011 · 108 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

A Strategy for Risk Management of Drug-Induced Phospholipidosis

Linda A. Chatman, Daniel Morton, Theodore Johnson et al. · Toxicologic Pathology · 2009 · 70 citations

Pharmacy, Pharmacology, Toxicology +14

Effects of feed restriction on fertility in female rats

Ketti K. Terry, Linda A. Chatman, George L. Foley et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2005 · 31 citations · Full text

Veterinary Medicine, Animal Sciences, Nutrition +15

The Relationship of Glucokinase Activator–induced Hypoglycemia with Arteriopathy, Neuronal Necrosis, and Peripheral Neuropathy in Nonclinical Studies

John C. Pettersen, John Litchfield, Natasha Neef et al. · Toxicologic Pathology · 2014 · 15 citations · Full text

Medicine, Biochemistry, Pharmacology +14